SILVAPHL Stock Overview
Engages in manufacture and marketing of pharmaceutical products in Bangladesh.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Silva Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳14.40 |
| 52 Week High | ৳21.60 |
| 52 Week Low | ৳13.40 |
| Beta | 0.020 |
| 11 Month Change | -4.64% |
| 3 Month Change | 3.60% |
| 1 Year Change | -33.33% |
| 33 Year Change | -36.56% |
| 5 Year Change | -29.35% |
| Change since IPO | -47.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| SILVAPHL | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | -2.7% | -2.5% | -2.6% |
| 1Y | -33.3% | -19.5% | -21.5% |
Return vs Industry: SILVAPHL underperformed the BD Pharmaceuticals industry which returned -19.5% over the past year.
Return vs Market: SILVAPHL underperformed the BD Market which returned -21.5% over the past year.
Price Volatility
| SILVAPHL volatility | |
|---|---|
| SILVAPHL Average Weekly Movement | 7.3% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in BD Market | 7.4% |
| 10% least volatile stocks in BD Market | 3.6% |
Stable Share Price: SILVAPHL has not had significant price volatility in the past 3 months.
Volatility Over Time: SILVAPHL's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 765 | Saira Khan | www.silvapharma.com |
Silva Pharmaceuticals Limited engages in manufacture and marketing of pharmaceutical products in Bangladesh. The company offers drugs for antibiotics, antifungals, analgesics, anti-diabetics, anti-pyretics, anti-inflammatory, anti-ulcerants, respiratory, cardiovascular, central nervous system, dermatology, gastrointenstinal, antiemetic and anti-spasmodic, antibacterial, allergies, cough, and cold, as well as natural sweetner, vitamins and minerals. It also provides medicine and vaccine for farmers and fisheries; agricultural chemicals and public health insecticides; and herbal and neutraceutical products.
Silva Pharmaceuticals Limited Fundamentals Summary
| SILVAPHL fundamental statistics | |
|---|---|
| Market cap | ৳1.97b |
| Earnings (TTM) | -৳30.91m |
| Revenue (TTM) | ৳611.62m |
3.2x
P/S Ratio-63.6x
P/E RatioIs SILVAPHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SILVAPHL income statement (TTM) | |
|---|---|
| Revenue | ৳611.62m |
| Cost of Revenue | ৳437.92m |
| Gross Profit | ৳173.70m |
| Other Expenses | ৳204.61m |
| Earnings | -৳30.91m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 28.40% |
| Net Profit Margin | -5.05% |
| Debt/Equity Ratio | 1.8% |
How did SILVAPHL perform over the long term?
See historical performance and comparison